Blood transfusion services amidst the COVID-19 pandemic

Published : 03 June 2021

Dr. Siti Salmah Noordin
Authors : Siti Salmah Noordin, Narazah Mohd Yusoff, Faraizah Abdul Karim, Soon Eu Chong
Titles of Publication : Blood transfusion services amidst the COVID-19 pandemic
Journal Name : Journal of Global Health
Quartile : Q1
Impact Factor : 2.899
Description : The year 2020 marked the beginning of a major change in the way we humans live and interact due to the COVID-19 pandemic. The causative agent of this disease is severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Due to the relatively mild symptoms in the early phase of infection, a long incubation period and a high infectivity rate, SARS-COV-2 has spread at lightning speed globally. To date, the number of COVID-19 cases has exceeded 120 million globally and continues to rise exponentially with a fatality ratio of 0.5%–1.0%, and this ratio increases with age. Despite headlines on COVID-19 vaccines and treatments, the ability of the virus to mutate leaves many uncertainties particularly with regard to the efficacies of vaccines and treatments. Healthcare services, including blood transfusion, have been significantly affected. This review aims to discuss the impact and suggest the best practice for transfusion services in this era of new norms.
Scroll to Top